IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v14y2017i2p216-d91142.html
   My bibliography  Save this article

DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma

Author

Listed:
  • Jin Huang

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, Hunan, China
    Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, Hunan, China)

  • Guo Wang

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, Hunan, China
    Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, Hunan, China)

  • Jie Tang

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, Hunan, China
    Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, Hunan, China)

  • Wei Zhuang

    (Department of Cardiovascular & Thoracic Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China)

  • Li-Ping Wang

    (Department of Clinical Oncology, The First People’s Hospital of Chenzhou, Chenzhou 423000, Hunan, China)

  • Yu-Ligh Liou

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, Hunan, China
    Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, Hunan, China
    iStat Biomedical Co. Ltd., Taipei 221, Taiwan)

  • Ying-Zi Liu

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, Hunan, China
    Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, Hunan, China)

  • Hong-Hao Zhou

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, Hunan, China
    Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, Hunan, China)

  • Yuan-Shan Zhu

    (Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, Hunan, China
    Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, Hunan, China)

Abstract

Hypermethylation of specific gene promoters is an important mechanism of carcinogenesis. A high frequency of promoter methylation of PAX1 and ZNF582 genes has been detected in cervical cancer. In the present study, we investigated the methylation status of PAX1 and ZNF582 genes in esophageal squamous cell carcinoma (ESCC) tissues. Tumor and paracancerous tissues were obtained from 14 ESCC patients. Genomic DNA was extracted from both tumor and paracancerous tissues, and the concentration of DNA were determined. DNA methylation analysis of PAX1 and ZNF582 genes was carried out using quantitative methylation-specific PCR. To assess the diagnostic performance of the two methylated genes for cancer detection, receiver operating characteristic (ROC) curves were generated. Sensitivities and specificities were tested at cut-offs obtained from the ROC curves. The methylation levels of both PAX1 and ZNF582 genes were significantly higher in tumor tissues compared to non-tumor paracancerous tissues. The methylation rates of PAX1 and ZNF582 in ESCC tumor and paracancerous tissues were 100% and 21.4% ( p = 0.006), 85.7% and 0% ( p < 0.001), respectively. The sensitivities and specificities of PAX1 and ZNF582 methylation for the detection of cancer were 100% and 85.7%, and 78.6% and 100%, respectively. The DNA methylation levels and frequencies of PAX1 and ZNF582 genes were markedly higher in ESCC tumor tissues compared to those in paracancerous tissues. Moreover, the conclusions were verified by using The Cancer Genome Atlas (TCGA) datasets. DNA methylation status of these two genes showed a relatively good sensitivity and specificity for the detection of ESCC tumors. This data suggests that DNA methylation testing holds a great promise for ESCC screening and warrants further prospective population-based studies.

Suggested Citation

  • Jin Huang & Guo Wang & Jie Tang & Wei Zhuang & Li-Ping Wang & Yu-Ligh Liou & Ying-Zi Liu & Hong-Hao Zhou & Yuan-Shan Zhu, 2017. "DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma," IJERPH, MDPI, vol. 14(2), pages 1-12, February.
    • Handle: RePEc:gam:jijerp:v:14:y:2017:i:2:p:216-:d:91142
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/14/2/216/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/14/2/216/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:14:y:2017:i:2:p:216-:d:91142. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.